nodes	percent_of_prediction	percent_of_DWPC	metapath
Riluzole—ABCG2—Irinotecan—colon cancer	0.175	0.266	CbGbCtD
Riluzole—ABCG2—Fluorouracil—colon cancer	0.168	0.255	CbGbCtD
Riluzole—ABCG2—Vincristine—colon cancer	0.153	0.233	CbGbCtD
Riluzole—ABCG2—Methotrexate—colon cancer	0.0925	0.141	CbGbCtD
Riluzole—CYP1A2—Fluorouracil—colon cancer	0.0692	0.105	CbGbCtD
Riluzole—Epistaxis—Capecitabine—colon cancer	0.000358	0.00104	CcSEcCtD
Riluzole—Discomfort—Fluorouracil—colon cancer	0.000357	0.00104	CcSEcCtD
Riluzole—Shock—Irinotecan—colon cancer	0.000356	0.00104	CcSEcCtD
Riluzole—Nervous system disorder—Irinotecan—colon cancer	0.000354	0.00103	CcSEcCtD
Riluzole—Agranulocytosis—Capecitabine—colon cancer	0.000354	0.00103	CcSEcCtD
Riluzole—Thrombocytopenia—Irinotecan—colon cancer	0.000354	0.00103	CcSEcCtD
Riluzole—Anorexia—Vincristine—colon cancer	0.000354	0.00103	CcSEcCtD
Riluzole—Hyperhidrosis—Irinotecan—colon cancer	0.000349	0.00102	CcSEcCtD
Riluzole—Confusional state—Fluorouracil—colon cancer	0.000349	0.00102	CcSEcCtD
Riluzole—Mood swings—Methotrexate—colon cancer	0.000347	0.00101	CcSEcCtD
Riluzole—Hypotension—Vincristine—colon cancer	0.000347	0.00101	CcSEcCtD
Riluzole—Bradycardia—Capecitabine—colon cancer	0.000347	0.00101	CcSEcCtD
Riluzole—Anaphylactic shock—Fluorouracil—colon cancer	0.000346	0.00101	CcSEcCtD
Riluzole—Oedema—Fluorouracil—colon cancer	0.000346	0.00101	CcSEcCtD
Riluzole—Anorexia—Irinotecan—colon cancer	0.000344	0.001	CcSEcCtD
Riluzole—Ataxia—Methotrexate—colon cancer	0.000344	0.001	CcSEcCtD
Riluzole—Infection—Fluorouracil—colon cancer	0.000344	0.001	CcSEcCtD
Riluzole—Haemoglobin—Capecitabine—colon cancer	0.000342	0.000998	CcSEcCtD
Riluzole—Rhinitis—Capecitabine—colon cancer	0.000341	0.000995	CcSEcCtD
Riluzole—Haemorrhage—Capecitabine—colon cancer	0.00034	0.000993	CcSEcCtD
Riluzole—Hepatitis—Capecitabine—colon cancer	0.00034	0.000993	CcSEcCtD
Riluzole—Nervous system disorder—Fluorouracil—colon cancer	0.000339	0.00099	CcSEcCtD
Riluzole—Thrombocytopenia—Fluorouracil—colon cancer	0.000339	0.000988	CcSEcCtD
Riluzole—Hypoaesthesia—Capecitabine—colon cancer	0.000339	0.000988	CcSEcCtD
Riluzole—Liver function test abnormal—Methotrexate—colon cancer	0.000338	0.000986	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Vincristine—colon cancer	0.000338	0.000986	CcSEcCtD
Riluzole—Pharyngitis—Capecitabine—colon cancer	0.000338	0.000985	CcSEcCtD
Riluzole—Tachycardia—Fluorouracil—colon cancer	0.000338	0.000985	CcSEcCtD
Riluzole—Hypotension—Irinotecan—colon cancer	0.000338	0.000985	CcSEcCtD
Riluzole—Urinary tract disorder—Capecitabine—colon cancer	0.000336	0.00098	CcSEcCtD
Riluzole—Insomnia—Vincristine—colon cancer	0.000336	0.000979	CcSEcCtD
Riluzole—Oedema peripheral—Capecitabine—colon cancer	0.000335	0.000978	CcSEcCtD
Riluzole—Connective tissue disorder—Capecitabine—colon cancer	0.000335	0.000976	CcSEcCtD
Riluzole—Urethral disorder—Capecitabine—colon cancer	0.000334	0.000973	CcSEcCtD
Riluzole—Paraesthesia—Vincristine—colon cancer	0.000333	0.000972	CcSEcCtD
Riluzole—Breast disorder—Methotrexate—colon cancer	0.000331	0.000965	CcSEcCtD
Riluzole—Anorexia—Fluorouracil—colon cancer	0.00033	0.000962	CcSEcCtD
Riluzole—Insomnia—Irinotecan—colon cancer	0.000327	0.000953	CcSEcCtD
Riluzole—Paraesthesia—Irinotecan—colon cancer	0.000324	0.000946	CcSEcCtD
Riluzole—Hypotension—Fluorouracil—colon cancer	0.000323	0.000943	CcSEcCtD
Riluzole—Decreased appetite—Vincristine—colon cancer	0.000323	0.000941	CcSEcCtD
Riluzole—Dyspnoea—Irinotecan—colon cancer	0.000322	0.00094	CcSEcCtD
Riluzole—Erythema multiforme—Capecitabine—colon cancer	0.000322	0.000939	CcSEcCtD
Riluzole—Somnolence—Irinotecan—colon cancer	0.000321	0.000937	CcSEcCtD
Riluzole—Gastrointestinal disorder—Vincristine—colon cancer	0.00032	0.000934	CcSEcCtD
Riluzole—Fatigue—Vincristine—colon cancer	0.00032	0.000933	CcSEcCtD
Riluzole—Eye disorder—Capecitabine—colon cancer	0.000318	0.000928	CcSEcCtD
Riluzole—Dyspepsia—Irinotecan—colon cancer	0.000318	0.000928	CcSEcCtD
Riluzole—Pain—Vincristine—colon cancer	0.000317	0.000925	CcSEcCtD
Riluzole—Constipation—Vincristine—colon cancer	0.000317	0.000925	CcSEcCtD
Riluzole—Asthma—Methotrexate—colon cancer	0.000317	0.000923	CcSEcCtD
Riluzole—Cardiac disorder—Capecitabine—colon cancer	0.000316	0.000921	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.000315	0.00092	CcSEcCtD
Riluzole—Decreased appetite—Irinotecan—colon cancer	0.000314	0.000916	CcSEcCtD
Riluzole—Insomnia—Fluorouracil—colon cancer	0.000313	0.000913	CcSEcCtD
Riluzole—Gastrointestinal disorder—Irinotecan—colon cancer	0.000312	0.00091	CcSEcCtD
Riluzole—Fatigue—Irinotecan—colon cancer	0.000312	0.000909	CcSEcCtD
Riluzole—Paraesthesia—Fluorouracil—colon cancer	0.000311	0.000906	CcSEcCtD
Riluzole—Pancreatitis—Methotrexate—colon cancer	0.00031	0.000905	CcSEcCtD
Riluzole—Pain—Irinotecan—colon cancer	0.000309	0.000901	CcSEcCtD
Riluzole—Constipation—Irinotecan—colon cancer	0.000309	0.000901	CcSEcCtD
Riluzole—Angiopathy—Capecitabine—colon cancer	0.000309	0.000901	CcSEcCtD
Riluzole—Dyspnoea—Fluorouracil—colon cancer	0.000309	0.0009	CcSEcCtD
Riluzole—Somnolence—Fluorouracil—colon cancer	0.000308	0.000897	CcSEcCtD
Riluzole—Immune system disorder—Capecitabine—colon cancer	0.000307	0.000897	CcSEcCtD
Riluzole—Mediastinal disorder—Capecitabine—colon cancer	0.000307	0.000895	CcSEcCtD
Riluzole—Chills—Capecitabine—colon cancer	0.000305	0.000891	CcSEcCtD
Riluzole—Dyspepsia—Fluorouracil—colon cancer	0.000305	0.000889	CcSEcCtD
Riluzole—Arrhythmia—Capecitabine—colon cancer	0.000304	0.000887	CcSEcCtD
Riluzole—Abdominal discomfort—Methotrexate—colon cancer	0.000304	0.000885	CcSEcCtD
Riluzole—Gastrointestinal pain—Vincristine—colon cancer	0.000303	0.000885	CcSEcCtD
Riluzole—Decreased appetite—Fluorouracil—colon cancer	0.000301	0.000877	CcSEcCtD
Riluzole—Alopecia—Capecitabine—colon cancer	0.000301	0.000877	CcSEcCtD
Riluzole—Pancytopenia—Methotrexate—colon cancer	0.000301	0.000877	CcSEcCtD
Riluzole—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000299	0.000871	CcSEcCtD
Riluzole—Mental disorder—Capecitabine—colon cancer	0.000298	0.00087	CcSEcCtD
Riluzole—Feeling abnormal—Irinotecan—colon cancer	0.000298	0.000868	CcSEcCtD
Riluzole—Malnutrition—Capecitabine—colon cancer	0.000296	0.000864	CcSEcCtD
Riluzole—Dysuria—Methotrexate—colon cancer	0.000296	0.000863	CcSEcCtD
Riluzole—Neutropenia—Methotrexate—colon cancer	0.000296	0.000863	CcSEcCtD
Riluzole—Pain—Fluorouracil—colon cancer	0.000296	0.000863	CcSEcCtD
Riluzole—Gastrointestinal pain—Irinotecan—colon cancer	0.000295	0.000862	CcSEcCtD
Riluzole—Abdominal pain—Vincristine—colon cancer	0.000293	0.000855	CcSEcCtD
Riluzole—Body temperature increased—Vincristine—colon cancer	0.000293	0.000855	CcSEcCtD
Riluzole—Flatulence—Capecitabine—colon cancer	0.000292	0.000852	CcSEcCtD
Riluzole—Erectile dysfunction—Methotrexate—colon cancer	0.000292	0.00085	CcSEcCtD
Riluzole—Dysgeusia—Capecitabine—colon cancer	0.00029	0.000846	CcSEcCtD
Riluzole—Photosensitivity reaction—Methotrexate—colon cancer	0.000289	0.000843	CcSEcCtD
Riluzole—Back pain—Capecitabine—colon cancer	0.000287	0.000836	CcSEcCtD
Riluzole—Body temperature increased—Irinotecan—colon cancer	0.000286	0.000833	CcSEcCtD
Riluzole—Abdominal pain—Irinotecan—colon cancer	0.000286	0.000833	CcSEcCtD
Riluzole—Feeling abnormal—Fluorouracil—colon cancer	0.000285	0.000832	CcSEcCtD
Riluzole—Muscle spasms—Capecitabine—colon cancer	0.000285	0.000831	CcSEcCtD
Riluzole—Pneumonia—Methotrexate—colon cancer	0.000284	0.000828	CcSEcCtD
Riluzole—Infestation NOS—Methotrexate—colon cancer	0.000282	0.000823	CcSEcCtD
Riluzole—Infestation—Methotrexate—colon cancer	0.000282	0.000823	CcSEcCtD
Riluzole—Depression—Methotrexate—colon cancer	0.000281	0.000821	CcSEcCtD
Riluzole—Tremor—Capecitabine—colon cancer	0.000278	0.00081	CcSEcCtD
Riluzole—Stomatitis—Methotrexate—colon cancer	0.000275	0.000803	CcSEcCtD
Riluzole—Ill-defined disorder—Capecitabine—colon cancer	0.000275	0.000802	CcSEcCtD
Riluzole—Urticaria—Fluorouracil—colon cancer	0.000275	0.000802	CcSEcCtD
Riluzole—Anaemia—Capecitabine—colon cancer	0.000274	0.000799	CcSEcCtD
Riluzole—Body temperature increased—Fluorouracil—colon cancer	0.000274	0.000798	CcSEcCtD
Riluzole—Hypersensitivity—Vincristine—colon cancer	0.000273	0.000797	CcSEcCtD
Riluzole—Sweating—Methotrexate—colon cancer	0.000271	0.000789	CcSEcCtD
Riluzole—Haematuria—Methotrexate—colon cancer	0.000269	0.000785	CcSEcCtD
Riluzole—Malaise—Capecitabine—colon cancer	0.000267	0.000779	CcSEcCtD
Riluzole—Hepatobiliary disease—Methotrexate—colon cancer	0.000267	0.000779	CcSEcCtD
Riluzole—Epistaxis—Methotrexate—colon cancer	0.000266	0.000777	CcSEcCtD
Riluzole—Vertigo—Capecitabine—colon cancer	0.000266	0.000777	CcSEcCtD
Riluzole—Hypersensitivity—Irinotecan—colon cancer	0.000266	0.000776	CcSEcCtD
Riluzole—Asthenia—Vincristine—colon cancer	0.000266	0.000776	CcSEcCtD
Riluzole—Syncope—Capecitabine—colon cancer	0.000266	0.000775	CcSEcCtD
Riluzole—Leukopenia—Capecitabine—colon cancer	0.000265	0.000774	CcSEcCtD
Riluzole—Agranulocytosis—Methotrexate—colon cancer	0.000263	0.000768	CcSEcCtD
Riluzole—Palpitations—Capecitabine—colon cancer	0.000262	0.000764	CcSEcCtD
Riluzole—Loss of consciousness—Capecitabine—colon cancer	0.00026	0.00076	CcSEcCtD
Riluzole—Asthenia—Irinotecan—colon cancer	0.000259	0.000756	CcSEcCtD
Riluzole—Cough—Capecitabine—colon cancer	0.000259	0.000754	CcSEcCtD
Riluzole—Hypertension—Capecitabine—colon cancer	0.000256	0.000746	CcSEcCtD
Riluzole—Hypersensitivity—Fluorouracil—colon cancer	0.000255	0.000744	CcSEcCtD
Riluzole—Haemoglobin—Methotrexate—colon cancer	0.000255	0.000743	CcSEcCtD
Riluzole—Diarrhoea—Vincristine—colon cancer	0.000254	0.00074	CcSEcCtD
Riluzole—Haemorrhage—Methotrexate—colon cancer	0.000253	0.000739	CcSEcCtD
Riluzole—Hepatitis—Methotrexate—colon cancer	0.000253	0.000739	CcSEcCtD
Riluzole—Myalgia—Capecitabine—colon cancer	0.000252	0.000736	CcSEcCtD
Riluzole—Chest pain—Capecitabine—colon cancer	0.000252	0.000736	CcSEcCtD
Riluzole—Arthralgia—Capecitabine—colon cancer	0.000252	0.000736	CcSEcCtD
Riluzole—Pharyngitis—Methotrexate—colon cancer	0.000252	0.000734	CcSEcCtD
Riluzole—Anxiety—Capecitabine—colon cancer	0.000251	0.000733	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000251	0.000731	CcSEcCtD
Riluzole—Urinary tract disorder—Methotrexate—colon cancer	0.00025	0.00073	CcSEcCtD
Riluzole—Discomfort—Capecitabine—colon cancer	0.000249	0.000727	CcSEcCtD
Riluzole—Urethral disorder—Methotrexate—colon cancer	0.000248	0.000725	CcSEcCtD
Riluzole—Diarrhoea—Irinotecan—colon cancer	0.000247	0.000721	CcSEcCtD
Riluzole—Dry mouth—Capecitabine—colon cancer	0.000247	0.00072	CcSEcCtD
Riluzole—Dizziness—Vincristine—colon cancer	0.000245	0.000716	CcSEcCtD
Riluzole—Pruritus—Fluorouracil—colon cancer	0.000245	0.000714	CcSEcCtD
Riluzole—Confusional state—Capecitabine—colon cancer	0.000244	0.000711	CcSEcCtD
Riluzole—Oedema—Capecitabine—colon cancer	0.000242	0.000705	CcSEcCtD
Riluzole—Infection—Capecitabine—colon cancer	0.00024	0.000701	CcSEcCtD
Riluzole—Erythema multiforme—Methotrexate—colon cancer	0.00024	0.000699	CcSEcCtD
Riluzole—Dizziness—Irinotecan—colon cancer	0.000239	0.000697	CcSEcCtD
Riluzole—Shock—Capecitabine—colon cancer	0.000238	0.000694	CcSEcCtD
Riluzole—Nervous system disorder—Capecitabine—colon cancer	0.000237	0.000692	CcSEcCtD
Riluzole—Eye disorder—Methotrexate—colon cancer	0.000237	0.000691	CcSEcCtD
Riluzole—Diarrhoea—Fluorouracil—colon cancer	0.000237	0.000691	CcSEcCtD
Riluzole—Thrombocytopenia—Capecitabine—colon cancer	0.000237	0.000691	CcSEcCtD
Riluzole—Tachycardia—Capecitabine—colon cancer	0.000236	0.000688	CcSEcCtD
Riluzole—Vomiting—Vincristine—colon cancer	0.000236	0.000688	CcSEcCtD
Riluzole—Cardiac disorder—Methotrexate—colon cancer	0.000235	0.000686	CcSEcCtD
Riluzole—Skin disorder—Capecitabine—colon cancer	0.000235	0.000685	CcSEcCtD
Riluzole—Rash—Vincristine—colon cancer	0.000234	0.000682	CcSEcCtD
Riluzole—Hyperhidrosis—Capecitabine—colon cancer	0.000234	0.000682	CcSEcCtD
Riluzole—Dermatitis—Vincristine—colon cancer	0.000234	0.000682	CcSEcCtD
Riluzole—Headache—Vincristine—colon cancer	0.000232	0.000678	CcSEcCtD
Riluzole—Anorexia—Capecitabine—colon cancer	0.000231	0.000672	CcSEcCtD
Riluzole—Angiopathy—Methotrexate—colon cancer	0.00023	0.000671	CcSEcCtD
Riluzole—Vomiting—Irinotecan—colon cancer	0.00023	0.00067	CcSEcCtD
Riluzole—Immune system disorder—Methotrexate—colon cancer	0.000229	0.000668	CcSEcCtD
Riluzole—Dizziness—Fluorouracil—colon cancer	0.000229	0.000667	CcSEcCtD
Riluzole—Mediastinal disorder—Methotrexate—colon cancer	0.000228	0.000666	CcSEcCtD
Riluzole—Rash—Irinotecan—colon cancer	0.000228	0.000665	CcSEcCtD
Riluzole—Dermatitis—Irinotecan—colon cancer	0.000228	0.000664	CcSEcCtD
Riluzole—Chills—Methotrexate—colon cancer	0.000227	0.000663	CcSEcCtD
Riluzole—Headache—Irinotecan—colon cancer	0.000226	0.00066	CcSEcCtD
Riluzole—Hypotension—Capecitabine—colon cancer	0.000226	0.000659	CcSEcCtD
Riluzole—Alopecia—Methotrexate—colon cancer	0.000224	0.000653	CcSEcCtD
Riluzole—Mental disorder—Methotrexate—colon cancer	0.000222	0.000648	CcSEcCtD
Riluzole—Malnutrition—Methotrexate—colon cancer	0.000221	0.000643	CcSEcCtD
Riluzole—Nausea—Vincristine—colon cancer	0.00022	0.000643	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Capecitabine—colon cancer	0.00022	0.000643	CcSEcCtD
Riluzole—Vomiting—Fluorouracil—colon cancer	0.00022	0.000642	CcSEcCtD
Riluzole—Insomnia—Capecitabine—colon cancer	0.000219	0.000638	CcSEcCtD
Riluzole—Rash—Fluorouracil—colon cancer	0.000218	0.000636	CcSEcCtD
Riluzole—Dermatitis—Fluorouracil—colon cancer	0.000218	0.000636	CcSEcCtD
Riluzole—Paraesthesia—Capecitabine—colon cancer	0.000217	0.000633	CcSEcCtD
Riluzole—Headache—Fluorouracil—colon cancer	0.000217	0.000632	CcSEcCtD
Riluzole—Dysgeusia—Methotrexate—colon cancer	0.000216	0.00063	CcSEcCtD
Riluzole—Dyspnoea—Capecitabine—colon cancer	0.000216	0.000629	CcSEcCtD
Riluzole—Nausea—Irinotecan—colon cancer	0.000215	0.000626	CcSEcCtD
Riluzole—Back pain—Methotrexate—colon cancer	0.000213	0.000622	CcSEcCtD
Riluzole—Dyspepsia—Capecitabine—colon cancer	0.000213	0.000621	CcSEcCtD
Riluzole—Decreased appetite—Capecitabine—colon cancer	0.00021	0.000613	CcSEcCtD
Riluzole—Gastrointestinal disorder—Capecitabine—colon cancer	0.000209	0.000609	CcSEcCtD
Riluzole—Fatigue—Capecitabine—colon cancer	0.000209	0.000608	CcSEcCtD
Riluzole—Pain—Capecitabine—colon cancer	0.000207	0.000603	CcSEcCtD
Riluzole—Constipation—Capecitabine—colon cancer	0.000207	0.000603	CcSEcCtD
Riluzole—Nausea—Fluorouracil—colon cancer	0.000206	0.0006	CcSEcCtD
Riluzole—Ill-defined disorder—Methotrexate—colon cancer	0.000205	0.000597	CcSEcCtD
Riluzole—Anaemia—Methotrexate—colon cancer	0.000204	0.000595	CcSEcCtD
Riluzole—Feeling abnormal—Capecitabine—colon cancer	0.000199	0.000581	CcSEcCtD
Riluzole—Malaise—Methotrexate—colon cancer	0.000199	0.00058	CcSEcCtD
Riluzole—Vertigo—Methotrexate—colon cancer	0.000198	0.000578	CcSEcCtD
Riluzole—Gastrointestinal pain—Capecitabine—colon cancer	0.000198	0.000577	CcSEcCtD
Riluzole—Leukopenia—Methotrexate—colon cancer	0.000197	0.000576	CcSEcCtD
Riluzole—Cough—Methotrexate—colon cancer	0.000192	0.000561	CcSEcCtD
Riluzole—Urticaria—Capecitabine—colon cancer	0.000192	0.00056	CcSEcCtD
Riluzole—Body temperature increased—Capecitabine—colon cancer	0.000191	0.000558	CcSEcCtD
Riluzole—Abdominal pain—Capecitabine—colon cancer	0.000191	0.000558	CcSEcCtD
Riluzole—Convulsion—Methotrexate—colon cancer	0.000191	0.000557	CcSEcCtD
Riluzole—Chest pain—Methotrexate—colon cancer	0.000188	0.000548	CcSEcCtD
Riluzole—Arthralgia—Methotrexate—colon cancer	0.000188	0.000548	CcSEcCtD
Riluzole—Myalgia—Methotrexate—colon cancer	0.000188	0.000548	CcSEcCtD
Riluzole—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	0.000187	0.000544	CcSEcCtD
Riluzole—Discomfort—Methotrexate—colon cancer	0.000186	0.000541	CcSEcCtD
Riluzole—Confusional state—Methotrexate—colon cancer	0.000182	0.000529	CcSEcCtD
Riluzole—Anaphylactic shock—Methotrexate—colon cancer	0.00018	0.000525	CcSEcCtD
Riluzole—Infection—Methotrexate—colon cancer	0.000179	0.000522	CcSEcCtD
Riluzole—Hypersensitivity—Capecitabine—colon cancer	0.000178	0.00052	CcSEcCtD
Riluzole—Nervous system disorder—Methotrexate—colon cancer	0.000177	0.000515	CcSEcCtD
Riluzole—Thrombocytopenia—Methotrexate—colon cancer	0.000176	0.000514	CcSEcCtD
Riluzole—Skin disorder—Methotrexate—colon cancer	0.000175	0.00051	CcSEcCtD
Riluzole—Hyperhidrosis—Methotrexate—colon cancer	0.000174	0.000508	CcSEcCtD
Riluzole—Asthenia—Capecitabine—colon cancer	0.000174	0.000506	CcSEcCtD
Riluzole—Anorexia—Methotrexate—colon cancer	0.000172	0.000501	CcSEcCtD
Riluzole—Pruritus—Capecitabine—colon cancer	0.000171	0.000499	CcSEcCtD
Riluzole—Hypotension—Methotrexate—colon cancer	0.000168	0.000491	CcSEcCtD
Riluzole—Diarrhoea—Capecitabine—colon cancer	0.000165	0.000483	CcSEcCtD
Riluzole—Musculoskeletal discomfort—Methotrexate—colon cancer	0.000164	0.000478	CcSEcCtD
Riluzole—Insomnia—Methotrexate—colon cancer	0.000163	0.000475	CcSEcCtD
Riluzole—Paraesthesia—Methotrexate—colon cancer	0.000162	0.000472	CcSEcCtD
Riluzole—Dyspnoea—Methotrexate—colon cancer	0.000161	0.000468	CcSEcCtD
Riluzole—Somnolence—Methotrexate—colon cancer	0.00016	0.000467	CcSEcCtD
Riluzole—Dizziness—Capecitabine—colon cancer	0.00016	0.000466	CcSEcCtD
Riluzole—Dyspepsia—Methotrexate—colon cancer	0.000158	0.000462	CcSEcCtD
Riluzole—Decreased appetite—Methotrexate—colon cancer	0.000157	0.000456	CcSEcCtD
Riluzole—Gastrointestinal disorder—Methotrexate—colon cancer	0.000155	0.000453	CcSEcCtD
Riluzole—Fatigue—Methotrexate—colon cancer	0.000155	0.000453	CcSEcCtD
Riluzole—Pain—Methotrexate—colon cancer	0.000154	0.000449	CcSEcCtD
Riluzole—Vomiting—Capecitabine—colon cancer	0.000154	0.000448	CcSEcCtD
Riluzole—Rash—Capecitabine—colon cancer	0.000152	0.000445	CcSEcCtD
Riluzole—Dermatitis—Capecitabine—colon cancer	0.000152	0.000444	CcSEcCtD
Riluzole—Headache—Capecitabine—colon cancer	0.000152	0.000442	CcSEcCtD
Riluzole—Feeling abnormal—Methotrexate—colon cancer	0.000148	0.000433	CcSEcCtD
Riluzole—Gastrointestinal pain—Methotrexate—colon cancer	0.000147	0.000429	CcSEcCtD
Riluzole—Nausea—Capecitabine—colon cancer	0.000144	0.000419	CcSEcCtD
Riluzole—Urticaria—Methotrexate—colon cancer	0.000143	0.000417	CcSEcCtD
Riluzole—Body temperature increased—Methotrexate—colon cancer	0.000142	0.000415	CcSEcCtD
Riluzole—Abdominal pain—Methotrexate—colon cancer	0.000142	0.000415	CcSEcCtD
Riluzole—Hypersensitivity—Methotrexate—colon cancer	0.000133	0.000387	CcSEcCtD
Riluzole—Asthenia—Methotrexate—colon cancer	0.000129	0.000377	CcSEcCtD
Riluzole—Pruritus—Methotrexate—colon cancer	0.000127	0.000372	CcSEcCtD
Riluzole—Diarrhoea—Methotrexate—colon cancer	0.000123	0.000359	CcSEcCtD
Riluzole—Dizziness—Methotrexate—colon cancer	0.000119	0.000347	CcSEcCtD
Riluzole—Vomiting—Methotrexate—colon cancer	0.000114	0.000334	CcSEcCtD
Riluzole—Rash—Methotrexate—colon cancer	0.000114	0.000331	CcSEcCtD
Riluzole—Dermatitis—Methotrexate—colon cancer	0.000113	0.000331	CcSEcCtD
Riluzole—Headache—Methotrexate—colon cancer	0.000113	0.000329	CcSEcCtD
Riluzole—Nausea—Methotrexate—colon cancer	0.000107	0.000312	CcSEcCtD
